Adage Capital Partners’s Immix Biopharma IMMX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMMX
SVCM
OM
Adage Capital Partners's IMMX Position: Q3 2026 in Review
Adage Capital Partners opened a new position in Immix Biopharma (IMMX) in Q3 2026: 727,272 shares worth $7.57M. The stake represents 0.01% of the portfolio and ranks #789 among its holdings. This is a return to the name: Adage Capital Partners previously reported a position in IMMX as recently as Q4 2025.
Adage Capital Partners first reported a position in IMMX in Q4 2025 and has held it in 2 quarters since. The position peaked at $7.84M in Q4 2025. 137 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.
- Adage Capital Partners held 727,272 shares of Immix Biopharma worth $7.57M as of Q3 2026.
- Immix Biopharma was a new Adage Capital Partners position in Q3 2026.
- Immix Biopharma made up 0.01% of Adage Capital Partners's portfolio in Q3 2026, its #789 holding.
- Adage Capital Partners first reported a position in Immix Biopharma in Q4 2025 and has held it in 2 quarters since.
- Adage Capital Partners's Immix Biopharma position peaked at $7.84M in Q4 2025.
- 137 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.
Based on Adage Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.